Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chronic inflammation in endometriosis and endometriosis-associated ovarian cancer: New roles for the "old" complement pathway.

Literature DB >> 26155393

Chronic inflammation in endometriosis and endometriosis-associated ovarian cancer: New roles for the "old" complement pathway.

Robert P Edwards¹, Xin Huang², Anda M Vlad².

Abstract

Immune escape is consequential for cancer development. Identifying abnormalities of the immune microenvironment during early carcinogenesis can provide insight into disease pathogenesis and unravel new preventive or therapeutic targets. We recently conducted a comprehensive immune gene expression analysis in endometriosis and endometriosis-associated ovarian cancer and explored new mechanistic roles for the complement pathway.

Entities: Disease

Keywords: atypical endometriosis; complement; endometriosis; endometriosis-associated ovarian cancer

Year: 2015 PMID： 26155393 PMCID： PMC4485759 DOI： 10.1080/2162402X.2014.1002732

Source DB: PubMed Journal: Oncoimmunology ISSN： 2162-4011 Impact factor: 8.110

10 in total

1. Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer.

Authors: Swati Suryawanshi; Xin Huang; Esther Elishaev; Raluca A Budiu; Lixin Zhang; SungHwan Kim; Nicole Donnellan; Gina Mantia-Smaldone; Tianzhou Ma; George Tseng; Ted Lee; Suketu Mansuria; Robert P Edwards; Anda M Vlad
Journal: Clin Cancer Res Date: 2014-10-07 Impact factor: 12.531

2. Ovarian atypical endometriosis: its close association with malignant epithelial tumours.

Authors: M Fukunaga; K Nomura; E Ishikawa; S Ushigome
Journal: Histopathology Date: 1997-03 Impact factor: 5.087

Review 3. The complement cascade as a mediator of tissue growth and regeneration.

Authors: Martin J Rutkowski; Michael E Sughrue; Ari J Kane; Brian J Ahn; Shanna Fang; Andrew T Parsa
Journal: Inflamm Res Date: 2010-06-02 Impact factor: 4.575

4. Immunobiology of human mucin 1 in a preclinical ovarian tumor model.

Authors: R A Budiu; E Elishaev; J Brozick; M Lee; R P Edwards; P Kalinski; A M Vlad
Journal: Oncogene Date: 2012-09-10 Impact factor: 9.867

5. A conditional mouse model for human MUC1-positive endometriosis shows the presence of anti-MUC1 antibodies and Foxp3+ regulatory T cells.

Authors: Raluca A Budiu; Iulia Diaconu; Rachel Chrissluis; Anica Dricu; Robert P Edwards; Anda M Vlad
Journal: Dis Model Mech Date: 2009-10-19 Impact factor: 5.758

6. Expression of natural cytotoxicity receptors on peritoneal fluid natural killer cell and cytokine production by peritoneal fluid natural killer cell in women with endometriosis.

Authors: Ayano Funamizu; Atsushi Fukui; Mai Kamoi; Kohei Fuchinoue; Megumi Yokota; Rie Fukuhara; Hideki Mizunuma
Journal: Am J Reprod Immunol Date: 2014-02-05 Impact factor: 3.886

7. Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer.

Authors: Swati Suryawanshi; Anda M Vlad; Hui-Min Lin; Gina Mantia-Smaldone; Robin Laskey; Minjae Lee; Yan Lin; Nicole Donnellan; Marcia Klein-Patel; Ted Lee; Suketu Mansuria; Esther Elishaev; Raluca Budiu; Robert P Edwards; Xin Huang
Journal: Clin Cancer Res Date: 2013-01-29 Impact factor: 12.531

Review 8. Screening for cancer in low- and middle-income countries.

Authors: R Sankaranarayanan
Journal: Ann Glob Health Date: 2014 Sep-Oct Impact factor: 2.462

9. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies.

Authors: Celeste Leigh Pearce; Claire Templeman; Mary Anne Rossing; Alice Lee; Aimee M Near; Penelope M Webb; Christina M Nagle; Jennifer A Doherty; Kara L Cushing-Haugen; Kristine G Wicklund; Jenny Chang-Claude; Rebecca Hein; Galina Lurie; Lynne R Wilkens; Michael E Carney; Marc T Goodman; Kirsten Moysich; Susanne K Kjaer; Estrid Hogdall; Allan Jensen; Ellen L Goode; Brooke L Fridley; Melissa C Larson; Joellen M Schildkraut; Rachel T Palmieri; Daniel W Cramer; Kathryn L Terry; Allison F Vitonis; Linda J Titus; Argyrios Ziogas; Wendy Brewster; Hoda Anton-Culver; Alexandra Gentry-Maharaj; Susan J Ramus; A Rebecca Anderson; Doerthe Brueggmann; Peter A Fasching; Simon A Gayther; David G Huntsman; Usha Menon; Roberta B Ness; Malcolm C Pike; Harvey Risch; Anna H Wu; Andrew Berchuck
Journal: Lancet Oncol Date: 2012-02-22 Impact factor: 41.316

Review 10. Complement inhibition in cancer therapy.

Authors: Ruben Pio; Daniel Ajona; John D Lambris
Journal: Semin Immunol Date: 2013-05-24 Impact factor: 10.671

10 in total

6 in total

1. Discovering the Deregulated Molecular Functions Involved in Malignant Transformation of Endometriosis to Endometriosis-Associated Ovarian Carcinoma Using a Data-Driven, Function-Based Analysis.

Authors: Chia-Ming Chang; Yi-Ping Yang; Jen-Hua Chuang; Chi-Mu Chuang; Tzu-Wei Lin; Peng-Hui Wang; Mu-Hsien Yu; Cheng-Chang Chang
Journal: Int J Mol Sci Date: 2017-11-06 Impact factor: 5.923

2. Integrating the dysregulated inflammasome-based molecular functionome in the malignant transformation of endometriosis-associated ovarian carcinoma.

Authors: Chia-Ming Chang; Mong-Lien Wang; Kai-Hsi Lu; Yi-Ping Yang; Chi-Mou Juang; Peng-Hui Wang; Ren-Jun Hsu; Mu-Hsien Yu; Cheng-Chang Chang
Journal: Oncotarget Date: 2017-12-18

Review 6. Endometriosis and endometriosis-associated cancers: new insights into the molecular mechanisms of ovarian cancer development.

Authors: Amy Dawson; Marta Llauradó Fernandez; Michael Anglesio; Paul J Yong; Mark S Carey
Journal: Ecancermedicalscience Date: 2018-01-25